http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014534168-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21F9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 |
| filingDate | 2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014534168-A |
| titleOfInvention | Use of clinoptilolite or clinoptilolite-containing mixtures for the manufacture of medical products |
| abstract | The present invention relates to the use of clinoptilolite or clinoptilolite-containing mixtures for the production of medical products or other pharmaceuticals for absorbing cesium ions and excreting them from the human or animal body. At that time, clinoptilolite is modified by purification and refinement. The product is suitable for reducing the absorption concentration of radioactive and non-radioactive cesium ions in the human or animal body by preventive and / or timely administration. Similarly, this medical product or pharmaceutical is already present in the living body for a certain period of time by taking, and is suitable for gradually reducing the concentration of absorbed cesium ions after taking it. |
| priorityDate | 2011-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.